中国中医药信息杂志2025，Vol.32Issue(7)：62-66,5.DOI:10.19879/j.cnki.1005-5304.202405617
中医药防治肠易激综合征临床试验注册现况分析
Analysis on Current Status of Clinical Trial Registration on TCM Prevention and Treatment of Irritable Bowel Syndrome
摘要
Abstract
Objective To explore the distribution characteristics and development trend of TCM prevention and treatment for irritable bowel syndrome(IBS)by analyzing the clinical trials of TCM prevention and treatment for IBS registered in China Clinical Trial Registry(ChiCTR).Methods The ChiCTR database was retrieved to collect and organize clinical trials related to the TCM prevention and treatment of IBS from the establishment of the database to May 1,2024.Characteristics of the included trials were analyzed and summarized using SPSS 25.0 and Excel 2021.Results A total of 73 clinical trials were included,of which 65 were pre-registered.The registered research projects involved 14 provincial-level administrative regions,including Beijing,Jiangsu,Guangdong,Shanghai,and Sichuan,and 46 clinical trial institutions,among which Beijing University of Chinese Medicine(6 items,7.89%)registered a higher number.The top three sources of research funding were,in order,local finance(26 items,35.62%),state finance(20 items,27.40%),and hospital funding(10 items,13.70%).The types of studies were predominantly interventional(68 items,93.15%),and the study designs were predominantly randomized parallel controlled studies(64 items,87.67%),but only 27 studies(36.99%)used a blinded approach.The main interventions included acupuncture and moxibustion,Chinese patent medicines,classic prescriptions/hospital-prepared remedies,etc.Conclusion The number of clinical research registrations in this field has been gradually increasing in recent years,but there are problems such as uneven regional distribution,low use of blinding,and lack of standardization of registration information.关键词
肠易激综合征/中医药/中国临床试验注册中心Key words
irritable bowel syndrome/TCM/Chinese Clinical Trial Registry分类
医药卫生引用本文复制引用
钱诗维,梁彪,黄硕,杨忆衡,王振宜..中医药防治肠易激综合征临床试验注册现况分析[J].中国中医药信息杂志,2025,32(7):62-66,5.基金项目
国家自然科学基金面上项目(82274531、81973859) （82274531、81973859）
上海市卫生健康委员会卫生行业临床研究专项面上项目(202140185) （202140185）
